Predictive Value of Serum Calcitonin Levels for Preoperative Diagnosis of Medullary Thyroid Carcinoma in a Cohort of 5817 Consecutive Patients with Thyroid Nodules
Open Access
- 21 November 2006
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 92 (2), 450-455
- https://doi.org/10.1210/jc.2006-1590
Abstract
Routine serum calcitonin (CT) measurement in patients with thyroid nodules for diagnosis of medullary thyroid carcinoma (MTC) is controversial. The objective of this study was to evaluate the diagnostic accuracy of systematic CT measurement in non-multiple endocrine neoplasia type 2 patients with nodular thyroid disease. This study was conducted at a national healthcare system hospital (outpatient and inpatient sectors). Consecutive patients with nodular thyroid disease (n = 5817) were studied. Serum CT levels were measured under basal conditions, and when basal values were more than or equal to 20 and less than 100 pg/ml, testing was repeated after pentagastrin stimulation. Basal or stimulated levels more than 100 pg/ml were indication for surgery. Fifteen cases of MTC and seven of C cell hyperplasia (CCH) were identified. MTCs were diagnosed in all patients with basal CT more than 100 pg/ml. The four patients with basal CT more than or equal to 50 and less than 100 pg/ml included two diagnosed with MTC and two with CCH. In 10 patients with basal levels more than or equal to 20 and less than 50 pg/ml, histology confirmed the presence of MTC in four, four others had CCH, and the remaining two were negative for thyroid malignancy. Positive predictive values for basal CT levels in the preoperative diagnosis of MTC were: 23.1% for values more than or equal to 20 pg/ml, 100% for values more than 100 pg/ml, 25% for levels more than or equal to 50 and less than 100 pg/ml, and 8.3% for values more than or equal to 20 and less than 50 pg/ml. Positive predictive values for the pentagastrin test (>100 pg/ml) were 40% in the entire series. CT screening of thyroid nodules is a highly sensitive test for early diagnosis of MTC, but confirmatory stimulation testing is necessary in most cases to identify true positive increases.Keywords
This publication has 24 references indexed in Scilit:
- Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid DisordersJournal of Clinical Endocrinology & Metabolism, 2004
- Can Sporadic Medullary Thyroid Carcinoma Be Biochemically Predicted? Prospective Analysis of 66 Operated Patients with Elevated Serum Calcitonin LevelsWorld Journal of Surgery, 2002
- Routine Measurement of Serum Calcitonin is Useful for Early Detection of Medullary Thyroid Carcinoma in Patients with Nodular Thyroid DiseasesThyroid®, 2001
- Preoperative Calcitonin Levels Are Predictive of Tumor Size and Postoperative Calcitonin Normalization in Medullary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2000
- Evaluation of Routine Basal Serum Calcitonin Measurement for Early Diagnosis of Medullary Thyroid Carcinoma in Seven Hundred Seventy-Three Patients with Nodular GoiterThyroid®, 1999
- Routine Measurement of Plasma Calcitonin in Nodular Thyroid DiseasesJournal of Clinical Endocrinology & Metabolism, 1997
- Interest of Routine Measurement of Serum Calcitonin: Study in a Large Series of Thyroidectomized PatientsJournal of Clinical Endocrinology & Metabolism, 1997
- Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodulesClinical Endocrinology, 1995
- The Importance of Early Diagnosis in Patients with Hereditary Medullary Thyroid CarcinomaAnnals of Surgery, 1982
- Early Diagnosis of Medullary Carcinoma of the Thyroid Gland by Means of Calcitonin AssayThe New England Journal of Medicine, 1971